MIM-727 Investigational Site
Nashville, Tennessee
We've found
1 trials
at this facility
Keratoconjunctivitis Sicca Clinical Trial
Updated: 12/17/2015
A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye
Status: Enrolling,
Phase
III
Updated: 12/17/2015
Click here to add this to my saved trials